Theracryf Plc (TCF.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2015 | 03-2014 | 03-2013 | |
| Cash Flows From Operating Activities | |||
| Accounts receivable | -20 | -68 | 12 |
| Other Working Capital | 81 | -38 | 63 |
| Other Operating Activity | -961 | -691 | -852 |
| Operating Cash Flow | $-900 | $-797 | $-777 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -1 | 0 | -2 |
| Purchase Sale Intangibles | 0 | 0 | -32 |
| Investing Cash Flow | $-1 | $0 | $-34 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 750 | 1,000 | 0 |
| Common Stock Issued | 0 | 0 | 454 |
| Other Financing Activity | 0 | -2 | -1 |
| Financing Cash Flow | $750 | $998 | $453 |
| Beginning Cash Position | 314 | 113 | 471 |
| End Cash Position | 163 | 314 | 113 |
| Net Cash Flow | $-151 | $201 | $-358 |
| Free Cash Flow | |||
| Operating Cash Flow | -900 | -797 | -777 |
| Capital Expenditure | -1 | N/A | -34 |
| Free Cash Flow | -901 | -797 | -811 |